Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

WGS vs NEO: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

NEO Wins Head-to-Head Institutional Verdict (4–2 across 6 Pillars · 7–3 Matrix Metrics)

NEO Overall Winner 6-Pillar Tally: WGS 2 – 4 NEO Matrix Metrics: WGS 3 – 7 NEO

As of Nov 16, 2026, NeoGenomics, Inc. (NEO) is the stronger overall head-to-head candidate over GeneDx Holdings Corp. (WGS) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). WGS carries a Unified Composite Score of 49.5/100 (HOLD) at $51.02 (40.6x Forward P/E, -13.7% operating margin), whereas NEO carries 35.0/100 (SELL) at $15.41 (N/M Forward P/E, -5.5% operating margin).

  • Composite vs. Pillar Nuance: While WGS currently prints a higher short-term Unified Composite Score (49.5/100 HOLD vs. NEO 35.0/100 SELL), NEO captures the overall institutional head-to-head verdict (7–3 matrix metrics and 4–2 across the 6 pillars) due to superior fundamental profitability (-5.5% vs. -13.7% operating margin) and revenue trajectory (+11.4% vs. +5.4% YoY).
  • Technical & Structure Timing Caution: WGS is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 34.8); meanwhile NEO is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 37.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About WGS vs NEO
WGS NASDAQ
GeneDx Holdings Corp. Class A Common Stock
Services-Health Services
$51.02
-2.58% 1D
Market Cap $1.6B
TTM Revenue $461M
Forward P/E 40.6x
Beta / 30D Vol 1.74β · 111% Vol
Unified Composite Score
49.5 / 100 HOLD
Tech 33.0 Fund 53.0 Flow 70.0 Mom 60.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -10.3%), weak momentum, RSI 35
RSI-14: 34.8 · SMA20: $62.47 · SMA50: $73.13
NEO NASDAQ Head-to-Head Winner
NeoGenomics, Inc.
Services-Testing Laboratories
$15.41
-3.81% 1D
Market Cap $2.1B
TTM Revenue $788M
Forward P/E N/M
Beta / 30D Vol 1.22β · 47% Vol
Unified Composite Score
35.0 / 100 SELL
Tech 21.0 Fund 44.0 Flow 58.0 Mom 60.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -0.2%), weak momentum, RSI 38
RSI-14: 37.8 · SMA20: $16.85 · SMA50: $17.51

6-Pillar Scorecard Institutional Category Breakdown (WGS 2 – 4 NEO)

Columns: Metric · WGS · NEO
1. Valuation Multiples WGS
Forward P/E 40.6x N/M
Trailing P/E 38.8x N/M
PEG Ratio N/M 2.09x
EV / Revenue 3.7x 3.0x
2. Growth & Scale NEO
Revenue Growth (YoY) +5.4% +11.4%
Earnings Growth (YoY) +0.0% +130.6%
TTM Revenue (USD) $461M $788M
Market Cap $1.6B $2.1B
3. Profitability & Quality NEO
Gross Margin 68.8% 44.8%
Operating Margin -13.7% -5.5%
Net Profit Margin -24.1% -4.1%
Return on Equity (ROE) -41.4% -3.9%
4. Balance Sheet & Cash Flow NEO
Cash Generation (TTM) -$101M -$29M
Cash Flow Margin -22.0% -3.6%
Net Cash / Leverage $119M Net Debt (0.88x D/E) $310M Net Debt (0.56x D/E)
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning NEO
Options Structure Phase BREAKDOWN CONSOLIDATION
Current IV / %ile 102.3% (21st %ile) 100.0% (14th %ile)
Put/Call OI Skew 7.82x (Put-Skewed) 0.12x (Call-Skewed)
OBV Trend / Tech Phase DISTRIBUTION · Markdown DISTRIBUTION · Markdown
6. R&D & Supply-Chain Moat WGS
OpEx & R&D Intensity 82.5% of Rev ($380M) 50.3% of Rev ($396M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Diagnostics & Research Operator Diagnostics & Research Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: WGS (3) vs NEO (7)
Institutional Metric WGS NEO Criterion Row Edge
Market Capitalization
Scale
$1.6B $2.1B Larger Scale NEO
Trailing P/E Ratio
Valuation
38.8x N/M Lower Multiple WGS
Forward P/E Ratio
Valuation
40.6x N/M Lower Multiple WGS
Revenue Growth (YoY)
Growth
+5.4% +11.4% Higher Growth NEO
Operating Margin (TTM)
Profitability
-13.7% -5.5% Higher Margin NEO
Net Profit Margin
Profitability
-24.1% -4.1% Higher Margin NEO
Return on Equity (ROE)
Capital Efficiency
-41.4% -3.9% Higher ROE NEO
52-Week Range Position
Momentum
14% ($32–$171) 64% ($7–$20) Stronger Trend NEO
Beta / 30D Volatility
Risk Regime
1.74β · 111% Vol 1.22β · 47% Vol Lower Realized Risk NEO
Unified Institutional Score
Composite Signal
49.5 / 100 (HOLD) 35.0 / 100 (SELL) Higher Composite WGS
Trailing 12M Revenue (USD)
Operating Scale
$461M $788M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
68.8% 44.8% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 3.7x EV/Rev 2.09x PEG · 3.0x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$101M ($119M Net Debt (0.88x D/E)) -$29M ($310M Net Debt (0.56x D/E)) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon NEO +12.34 pp
WGS: -19.79% · NEO: -7.45%
3M Horizon NEO +30.09 pp
WGS: -33.17% · NEO: -3.08%
6M Horizon NEO +64.6 pp
WGS: +19.51% · NEO: +84.11%
1Y Horizon NEO +114.81 pp
WGS: -60.86% · NEO: +53.95%

Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant USD Revenue & Operating Margin (%)
Period WGS Revenue NEO Revenue WGS Op. Margin NEO Op. Margin Margin Leader
FY2018 N/A $280M N/A 3.6% NEO
FY2019 $200M $410M -15.5% 3.2% NEO
FY2020 $180M $440M -134.9% -3.1% NEO
FY2021 $210M $480M -210.3% -24.5% NEO
FY2022 $230M $510M -284.5% -30.9% NEO
FY2023 $200M $590M -89.2% -18.2% NEO
FY2024 $310M $660M -7.6% -13.9% WGS
FY2025 $430M $730M -3.1% -15.9% WGS

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
WGS BREAKDOWN
96d in phase · OBV DISTRIBUTION
Current IV 102.3%
IV Percentile 21st %ile
Put/Call OI Skew 7.82x (Put-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BEARISH
OBV Flow DISTRIBUTION
Exact WGS Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
NEO CONSOLIDATION
69d in phase · OBV DISTRIBUTION
Current IV 100.0%
IV Percentile 14th %ile
Put/Call OI Skew 0.12x (Call-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow DISTRIBUTION
Exact NEO Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
WGS Moat Profile Cyclical / Execution-Driven Positioning
Diagnostics & Research Operator
Competes within the Diagnostics & Research value chain with $1.6B market capitalization and -13.7% operating margin.
OpEx & R&D Reinvestment 82.5% of Rev ($380M)
90D Engineering Disclosures 0 Published
NEO Moat Profile Cyclical / Execution-Driven Positioning
Diagnostics & Research Operator
Competes within the Diagnostics & Research value chain with $2.1B market capitalization and -5.5% operating margin.
OpEx & R&D Reinvestment 50.3% of Rev ($396M)
90D Engineering Disclosures 0 Published

Investor FAQ WGS vs NEO Key Questions & Quantitative Answers

As of Nov 16, 2026, NeoGenomics, Inc. (NEO) is the stronger overall head-to-head candidate over GeneDx Holdings Corp. (WGS) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). WGS carries a Unified Composite Score of 49.5/100 (HOLD) at $51.02 (40.6x Forward P/E, -13.7% operating margin), whereas NEO carries 35.0/100 (SELL) at $15.41 (N/M Forward P/E, -5.5% operating margin). Composite vs. Pillar Nuance: While WGS currently prints a higher short-term Unified Composite Score (49.5/100 HOLD vs. NEO 35.0/100 SELL), NEO captures the overall institutional head-to-head verdict (7–3 matrix metrics and 4–2 across the 6 pillars) due to superior fundamental profitability (-5.5% vs. -13.7% operating margin) and revenue trajectory (+11.4% vs. +5.4% YoY). Technical & Structure Timing Caution: WGS is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 34.8); meanwhile NEO is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 37.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

NEO leads the Growth & Scale pillar: WGS posts +5.4% YoY revenue growth and +0.0% YoY earnings growth on $461M TTM revenue (68.8% gross margin, -13.7% operating margin), compared with NEO at +11.4% YoY revenue growth and +130.6% YoY earnings growth on $788M TTM revenue (44.8% gross margin, -5.5% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), WGS cumulative revenue shifted +115.0% while NEO shifted +160.7%. In operating R&D and SG&A reinvestment, WGS deploys 82.5% of Rev ($380M) (0 90-day corporate R&D disclosures) versus 50.3% of Rev ($396M) (0 disclosures) for NEO.

WGS screens cheaper on headline valuation multiples. WGS trades at 40.6x Forward P/E, 38.8x Trailing P/E, N/M PEG, and 3.7x EV/Revenue (-22.0% FCF margin), whereas NEO trades at N/M Forward P/E, N/M Trailing P/E, 2.09x PEG, and 3.0x EV/Revenue (-3.6% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against WGS (-41.4% ROE) versus NEO (-3.9% ROE) capital efficiency.

In options market volatility and institutional positioning, WGS carries 102.3% implied volatility (21st %ile, Compressed (<25th %ile)), a 7.82x (Put-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a BREAKDOWN options structure phase (1.74β · 111% Vol realized risk). By comparison, NEO carries 100.0% implied volatility (14th %ile, Compressed (<25th %ile)), a 0.12x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (1.22β · 47% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.